Xin Lang Cai Jing·2025-09-17 13:03Core Insights - Suning Universal is focusing on a dual business strategy of real estate and medical aesthetics, aiming for collaborative development in both sectors [3] Group 1: Investor Relations Activity - The investor relations activity took place on September 17, 2025, in Nanjing, with participation from 20 institutions including Guotai Junan Securities and Guosheng Securities [2] - Key personnel from Suning Universal included Vice President Jiang Libo, Financial Head Liu Debo, and Medical Aesthetics Group's Ma Guoyi [2] Group 2: Business Development Strategy - Suning Universal is committed to its dual business strategy, emphasizing real estate development and sales while expanding into the medical aesthetics sector [3] - The real estate business is well-established, particularly in the Yangtze River Delta region, with a total land reserve of over 1.55 million square meters, primarily in economically developed areas [3] - The company has a low debt ratio of 29.74% as of mid-2025, indicating strong financial health [3] Group 3: Medical Aesthetics Sector - The medical aesthetics segment has seen significant investment, with seven operational medical aesthetics institutions, including the recently opened Suya Medical Aesthetics in Wuxi [3] - In the first half of 2025, pre-sales in the medical aesthetics sector reached 92.829 million yuan, marking an 18% year-on-year increase [3] - Future plans include expanding the medical aesthetics business through new store openings, acquisitions, and optimizing the supply chain to reduce costs [3] Group 4: Shareholder Returns - Suning Universal has a history of cash dividends, with a total of 966 million yuan distributed since 2022, and plans to continue rewarding shareholders through stable performance and growth [3]